RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eurobio Scientific Stock

Eurobio Scientific Liabilities 2024

Eurobio Scientific Liabilities

141.32 M EUR

Ticker

ALERS.PA

ISIN

FR0013240934

WKN

A2DVTN

In 2024, Eurobio Scientific's total liabilities amounted to 141.32 M EUR, a -10.6% difference from the 158.08 M EUR total liabilities in the previous year.

Eurobio Scientific Aktienanalyse

What does Eurobio Scientific do?

Eurobio Scientific SA is a French company specializing in the development and marketing of diagnostic and research products in the field of biology. It was founded in 2007 as a spin-off from the Pierre and Marie Curie University and is headquartered in Paris. Since 2017, the company has been listed on Euronext Growth in Paris. The company's business model is based on clear divisional structure with various product lines, including clinical diagnostics, research diagnostics, blood bank diagnostics, food analysis, and animal health research. Eurobio Scientific SA operates in over 60 countries and has a strong presence in Europe and Asia. Its notable products include the COVID-19 antibody test ELISA, a rapid COVID-19 test based on immuno-chromatography, and an All-In-One PCR test system for detecting COVID-19. This system allows for the rapid identification of the virus through a single reaction tube. Overall, Eurobio Scientific SA is an innovative company committed to constant product development and improvement, and its diverse product portfolio and international presence highlight its strength and position as an emerging player in the field of diagnostic and research products. Eurobio Scientific ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Eurobio Scientific's Liabilities

Eurobio Scientific's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Eurobio Scientific's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Eurobio Scientific's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Eurobio Scientific's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Eurobio Scientific’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Eurobio Scientific stock

What is the level of liabilities of Eurobio Scientific this year?

Eurobio Scientific has a debt balance of 141.32 M EUR this year.

What were the liabilities of Eurobio Scientific compared to the previous year?

The liabilities of Eurobio Scientific have increased by -10.6% dropped compared to the previous year.

What are the consequences of high debt for investors of Eurobio Scientific?

High liabilities can pose a risk for investors of Eurobio Scientific, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Eurobio Scientific?

Low liabilities mean that Eurobio Scientific has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Eurobio Scientific affect the company?

An increase in liabilities of Eurobio Scientific can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Eurobio Scientific affect the company?

A decrease in the liabilities of Eurobio Scientific can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Eurobio Scientific?

Some factors that can influence the liabilities of Eurobio Scientific include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Eurobio Scientific so important for investors?

The liabilities of Eurobio Scientific are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Eurobio Scientific take to modify the liabilities?

To change its liabilities, Eurobio Scientific can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Eurobio Scientific pay?

Over the past 12 months, Eurobio Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Eurobio Scientific is expected to pay a dividend of 0 EUR.

What is the dividend yield of Eurobio Scientific?

The current dividend yield of Eurobio Scientific is .

When does Eurobio Scientific pay dividends?

Eurobio Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Eurobio Scientific?

Eurobio Scientific paid dividends every year for the past 0 years.

What is the dividend of Eurobio Scientific?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Eurobio Scientific located?

Eurobio Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurobio Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurobio Scientific from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Eurobio Scientific pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Eurobio Scientific in the year 2023?

In the year 2023, Eurobio Scientific distributed 0 EUR as dividends.

In which currency does Eurobio Scientific pay out the dividend?

The dividends of Eurobio Scientific are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eurobio Scientific

Our stock analysis for Eurobio Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurobio Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.